These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 8797768)

  • 1. Reversal by hyaluronidase of adhesion-dependent multicellular drug resistance in mammary carcinoma cells.
    Croix BS; Rak JW; Kapitain S; Sheehan C; Graham CH; Kerbel RS
    J Natl Cancer Inst; 1996 Sep; 88(18):1285-96. PubMed ID: 8797768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid acquisition of multicellular drug resistance after a single exposure of mammary tumor cells to antitumor alkylating agents.
    Graham CH; Kobayashi H; Stankiewicz KS; Man S; Kapitain SJ; Kerbel RS
    J Natl Cancer Inst; 1994 Jul; 86(13):975-82. PubMed ID: 8007019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of intrinsic and acquired forms of drug resistance by hyaluronidase treatment of solid tumors.
    St Croix B; Man S; Kerbel RS
    Cancer Lett; 1998 Sep; 131(1):35-44. PubMed ID: 9839618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction and reversal of cell adhesion-dependent multicellular drug resistance in solid breast tumors.
    Kerbel RS; St Croix B; Florenes VA; Rak J
    Hum Cell; 1996 Dec; 9(4):257-64. PubMed ID: 9183656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of multicellular drug resistance observed in human ovarian and prostate carcinoma treated with the proteasome inhibitor PS-341.
    Frankel A; Man S; Elliott P; Adams J; Kerbel RS
    Clin Cancer Res; 2000 Sep; 6(9):3719-28. PubMed ID: 10999766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired multicellular-mediated resistance to alkylating agents in cancer.
    Kobayashi H; Man S; Graham CH; Kapitain SJ; Teicher BA; Kerbel RS
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3294-8. PubMed ID: 8475071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical characterization of in vivo alkylating agent resistance of a murine EMT-6 mammary carcinoma. Implication for systemic involvement in the resistance phenotype.
    Chen G; Teicher BA; Frei E
    Cancer Biochem Biophys; 1998 Jun; 16(1-2):139-55. PubMed ID: 9923973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the cyclin-dependent kinases inhibitor p27 on resistance of ovarian cancer multicellular spheroids to anticancer chemotherapy.
    Xing H; Wang S; Hu K; Tao W; Li J; Gao Q; Yang X; Weng D; Lu Y; Ma D
    J Cancer Res Clin Oncol; 2005 Aug; 131(8):511-9. PubMed ID: 15924242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical studies and clinical correlation of the effect of alkylating dose.
    Frei E; Teicher BA; Holden SA; Cathcart KN; Wang YY
    Cancer Res; 1988 Nov; 48(22):6417-23. PubMed ID: 3180059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta 1 overexpression produces drug resistance in vivo: reversal by decorin.
    Teicher BA; Ikebe M; Ara G; Keyes SR; Herbst RS
    In Vivo; 1997; 11(6):463-72. PubMed ID: 9509296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abrogation of taxol-induced G2-M arrest and apoptosis in human ovarian cancer cells grown as multicellular tumor spheroids.
    Frankel A; Buckman R; Kerbel RS
    Cancer Res; 1997 Jun; 57(12):2388-93. PubMed ID: 9192815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiadhesive antibodies targeting E-cadherin sensitize multicellular tumor spheroids to chemotherapy in vitro.
    Green SK; Francia G; Isidoro C; Kerbel RS
    Mol Cancer Ther; 2004 Feb; 3(2):149-59. PubMed ID: 14985455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide attenuates resistance to doxorubicin in three-dimensional aggregates of human breast carcinoma cells.
    Muir CP; Adams MA; Graham CH
    Breast Cancer Res Treat; 2006 Mar; 96(2):169-76. PubMed ID: 16331349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression analysis of tumor spheroids reveals a role for suppressed DNA mismatch repair in multicellular resistance to alkylating agents.
    Francia G; Man S; Teicher B; Grasso L; Kerbel RS
    Mol Cell Biol; 2004 Aug; 24(15):6837-49. PubMed ID: 15254249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E-Cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27(KIP1).
    St Croix B; Sheehan C; Rak JW; Flørenes VA; Slingerland JM; Kerbel RS
    J Cell Biol; 1998 Jul; 142(2):557-71. PubMed ID: 9679152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between tumour geometry and the response of tumour cells to cytotoxic drugs--an in vitro study using EMT6 multicellular spheroids.
    Kwok TT; Twentyman PR
    Int J Cancer; 1985 May; 35(5):675-82. PubMed ID: 3997287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Impact of cyclin-dependent kinase inhibitor p27 on resistance of ovarian cancer multicellular spheroids to taxol].
    Xing H; Li J; Gao QL; Wu JH; Gao C; Lu YP; Ma D
    Zhonghua Yi Xue Za Zhi; 2003 Jan; 83(1):37-41. PubMed ID: 12757643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate carcinoma response to cytotoxic therapy: in vivo resistance.
    Teicher BA; Kakeji Y; Ara G; Herbst RS; Northey D
    In Vivo; 1997; 11(6):453-61. PubMed ID: 9509295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor efficacy and pharmacokinetic analysis of 4-hydroperoxycyclophosphamide in comparison with cyclophosphamide +/- hepatic enzyme effectors.
    Teicher BA; Holden SA; Goff DA; Wright JE; Tretyakov O; Ayash LJ
    Cancer Chemother Pharmacol; 1996; 38(6):553-60. PubMed ID: 8823498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute in vivo resistance in high-dose therapy.
    Teicher BA; Ara G; Keyes SR; Herbst RS; Frei E
    Clin Cancer Res; 1998 Feb; 4(2):483-91. PubMed ID: 9516940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.